Invesco Mort SEC Filings

Invesco Mortgage Capital Inc. (IVR) reported an insider transaction by a company director. On 11/10/2025, the director sold 2,000 shares of the company’s 7.50% Series C Preferred Stock at a price of $24.722 per share (transaction code S).

Following the sale, the reporting person beneficially owns 0 shares of the Series C Preferred Stock and 19,258 shares of Common Stock, with ownership reported as direct.

Invesco Mortgage Capital (IVR) reported stronger Q3 2025 results. Net income was $53.471 million, with $50.208 million attributable to common stockholders, or $0.74 per diluted share. Net interest income improved to $17.614 million as interest expense declined to $55.302 million. Investment gains totaled $49.540 million, partly offset by a $9.218 million loss on derivatives.

Mortgage‑backed securities at fair value stood at $5.749 billion, and repurchase agreements were $5.150 billion with a 4.35% weighted average rate and 21 days weighted average remaining maturity. Total stockholders’ equity was $769.581 million. The company sold 4,638,385 common shares for $36.145 million net and repurchased 89,223 Series C preferred shares. A $0.34 per‑share common dividend (aggregate $24.121 million) was declared September 24 and paid October 24. Shares outstanding were 70,945,571 as of October 31, 2025.

Invesco Mortgage Capital Inc. (IVR) furnished Q3 results and an updated book value estimate. The company announced an estimated book value per common share in the range of $8.31 to $8.65 as of October 24, 2025. The estimate accompanies a press release covering financial results for the quarter ended September 30, 2025, which was provided as an exhibit.

The book value per share estimate is adjusted to exclude a pro rata portion of the current quarter’s common dividend and is calculated as total stockholders’ equity less the $172.6 million liquidation preference of the Series C Preferred Stock, divided by 70.9 million total common shares outstanding. This range offers a snapshot of equity value per common share around late October and reflects the capital structure impact of preferred stock.

Invesco Mortgage Capital Inc. announced planned director retirements and Board leadership changes. John Day, independent director and Chair, will retire from the Board effective December 31, 2025, and step down as Chair on November 4, 2025. Carolyn Handlon, independent director and Audit Committee Chair, will not seek re-election at the 2026 annual meeting and will retire as Audit Committee Chair on December 31, 2025 while remaining on the Board through the 2026 meeting. Carolyn Gibbs, executive director, will retire from the Board effective March 31, 2026. The Board elected Don Liu to be Chair effective November 4, 2025, named Wes McMullan to chair the Nomination and Corporate Governance Committee effective November 4, 2025, and named Robert Fleshman to chair the Audit Committee effective January 1, 2026; the Board will be reduced from eight to seven directors effective January 1, 2026.

Invesco Mortgage Capital Inc. has entered into an equity distribution agreement that allows it to offer up to 25,000,000 shares of its common stock through several placement agents. The shares are registered under the company’s effective Form S-3 shelf registration and a prospectus supplement has been filed to permit sales from time to time, including ordinary brokers’ transactions on the NYSE or negotiated or block transactions.

The agreement specifies placement agent compensation of up to 2.00% of gross proceeds, includes customary representations, warranties and indemnities, and states that neither the company nor the placement agents are obligated to effect any sales. The company also terminated its prior equity distribution agreement (which had permitted up to 18,000,000 shares) and previously sold approximately 11,425,638 shares under that prior program with no termination penalties.

Invesco Mortgage Capital Inc. is offering up to 25,000,000 shares of common stock through an equity distribution agreement with BTIG, Citizens JMP, Janney and JonesTrading as sales agents. Shares may be sold ‘‘at the market’’ on the NYSE (symbol IVR) or by negotiated transactions; the last reported sale price in the supplement was $7.61 per share. Sales agents may receive up to 2.0% of gross proceeds as compensation and the company estimates offering expenses of approximately $240,000 plus FINRA counsel fee reimbursements up to $5,000.

Proceeds will be added to general corporate funds and may be used for new investments, to repay indebtedness or other corporate purposes. To preserve REIT status, ownership is limited to 9.8% unless waived by the board. The supplement highlights material risks including potential dilution, post-offering share price volatility, outstanding preferred stock preferences (notably Series C preferred shares outstanding), and that management has broad discretion over use of proceeds. The supplement also notes tax law changes in the OBBBA affecting qualified REIT dividends and the TRS asset test.

Invesco Mortgage Capital Inc. (IVR) reported results for the quarter ended June 30, 2025 showing continued focus on mortgage-backed securities with total assets of $5.40 billion and MBS at fair value of $5.19 billion. The company earned higher net interest income of $17.7 million in the quarter versus $8.6 million a year earlier, driven by higher interest income and lower interest expense. For the three months ended June 30, 2025 the company recorded a net loss of $23.3 million and net loss attributable to common stockholders of $26.6 million, or $(0.40) per share.

Derivative activity materially affected results: loss on derivative instruments was $30.9 million in the quarter and $107.6 million for the six months. Six-month results included a $76.9 million gain on investments versus a prior-year loss. Repurchase agreements funded $4.64 billion of borrowings with collateral coverage at 105%. Book value per common share declined to $8.05 from $8.92 at year-end driven by derivative losses, dividends and expenses. Available liquidity (cash and restricted cash) totaled $190.5 million at period end.